Pharmaceutical giant Merck & Co., known internationally as MSD, has begun construction on a $3 billion, 400,000-square-foot manufacturing facility in Elkton, marking one of the largest life sciences investments in Virginia’s history.

The new plant — officially designated as Merck’s Center of Excellence for Pharmaceutical Ingredients and Small Molecule Manufacturing — will create 500 new jobs and significantly expand the company’s 85-year presence in the Shenandoah Valley.

Governor Glenn Youngkin announced the project Monday, calling it a “transformational investment” for both Virginia’s economy and the nation’s pharmaceutical landscape.

“Merck’s $3 billion commitment marks a giant leap forward for America’s and Virginia’s life sciences sector,” Youngkin said. “This project will bring hundreds of new jobs and world-class innovation to the Shenandoah Valley.”

The announcement reflects an expanded version of Merck’s original plan, which called for a $2 billion investment and 300 new positions. The increase is part of Merck’s $70 billion nationwide initiative to strengthen domestic research, development, and production capabilities.

Merck Chairman and CEO Robert M. Davis described the project as “an important milestone for Merck, for Virginia, and most importantly, for the patients we serve.”

Once complete, the new facility will feature cutting-edge technology for active pharmaceutical ingredient (API) production and small-molecule drug manufacturing and testing, complementing Merck’s long-standing operations already based in Elkton.

Virginia Secretary of Commerce and Trade Juan Pablo Segura praised the expansion as a “transformational move” that cements the Commonwealth’s reputation as a leader in pharmaceutical innovation. Rockingham County Board of Supervisors Chairman Joel Hensley echoed the sentiment, calling the groundbreaking “a proud and momentous occasion.”

The Virginia Economic Development Partnership, Rockingham County, and the Shenandoah Valley Partnershipworked together to secure the project. To support the expansion, Governor Youngkin approved a $5 million Virginia Investment Performance Grant and a $4 million Commonwealth’s Opportunity Fund Grant.

In addition, Merck’s workforce development will be supported through the Virginia Talent Accelerator Program, ranked as the top customized training program in the nation for three consecutive years. The program will provide tailored, no-cost training for employees based on international best practices.

Local lawmakers, including Senator Mark Obenshain and Delegate Tony Wilt, applauded the project as a major win for the regional economy and a testament to Merck’s enduring commitment to the Shenandoah Valley.

Source: Rocktown Now

Elvis Duran